Jasper Therapeutics Inc (JSPR) — Financial Flexibility Index
Jasper Therapeutics Inc (JSPR) has a Financial Flexibility Index of -0.69x as of December 2025. Free cash flow of $-21.87 Million (operating CF $-21.87 Million minus capex $0.00) represents -1% of total liabilities ($31.63 Million). Also explore JSPR net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Jasper Therapeutics Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Jasper Therapeutics Inc across 7 annual periods. Check JSPR capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Jasper Therapeutics Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Jasper Therapeutics Inc. For the full company profile including market capitalisation, see Jasper Therapeutics Inc (JSPR) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.44x | $-77.15 Million | $-77.16 Million | $31.63 Million | ▲ +28.4% |
| 2024 | -3.40x | $-62.05 Million | $-62.60 Million | $18.23 Million | ▼ -8.1% |
| 2023 | -3.15x | $-51.80 Million | $-52.07 Million | $16.45 Million | ▲ +14.0% |
| 2022 | -3.66x | $-45.28 Million | $-45.86 Million | $12.37 Million | ▼ -182.7% |
| 2021 | -1.29x | $-31.25 Million | $-33.68 Million | $24.14 Million | ▼ -378.1% |
| 2020 | -0.27x | $-15.84 Million | $-18.27 Million | $58.49 Million | ▼ -460.4% |
| 2019 | 0.08x | $459.00K | $-1.97 Million | $6.11 Million | — |